Form 6-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of June 2007

Commission File Number: 001-31368

 

SANOFI-AVENTIS

(Translation of registrant’s name into English)

 

174, avenue de France, 75013 Paris, FRANCE

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F  x            Form 40-F  ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):             

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):             

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes  ¨            No  x

If “Yes” marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-            

 

In June 2007, sanofi-aventis issued the press releases attached hereto as Exhibit 99.1 and 99.2 which are incorporated herein by reference.

Exhibit List

 

Exhibit No.  

Description

Exhibit 99.1   Press release dated June 29, 2007 regarding the Rimonabant regulatory update in Europe.
Exhibit 99.2   Press release dated June 29, 2007 regarding the Rimonabant regulatory update in the United States.

 

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Dated: July 2nd, 2007   SANOFI-AVENTIS
  By:  

/S/ Patricia Kodyra

  Name:   Patricia Kodyra
  Title:   Associate Vice President
    Financial and Securities Law

 

3

Exhibit Index

 

Exhibit No.  

Description

Exhibit 99.1   Press release dated June 29, 2007 regarding the Rimonabant regulatory update in Europe.
Exhibit 99.2   Press release dated June 29, 2007 regarding the Rimonabant regulatory update in the United States.

 

4